Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
AM Pharma
About
AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.
- 101 - 250
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €24M
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 101 - 250
- Operating Status
- Active
AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2020 | Debt Financing | €24M | 1 |
European Investment Bank
|
— | Detail |
| May 11, 2015 | Corporate Round | — | 1 | — | — | Detail |
| Feb 26, 2002 | Series B | — | 1 | — | — | Detail |
| Aug 9, 2001 | Series A | €640K | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Debt Financing |
Pfizer
|
— | Corporate Round |
|
|
— | Series B |
